Published in J Neural Transm Park Dis Dement Sect on January 01, 1993
The role of liver-derived insulin-like growth factor-I. Endocr Rev (2009) 1.87
Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc Natl Acad Sci U S A (2004) 1.75
Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res (2012) 1.48
Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease. Drugs (2012) 1.05
Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy. Neurology (2014) 1.04
Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases. Alzheimers Res Ther (2009) 1.00
Differences in abundances of cell-signalling proteins in blood reveal novel biomarkers for early detection of clinical Alzheimer's disease. PLoS One (2011) 0.94
Aberrant insulin signaling in Alzheimer's disease: current knowledge. Front Neurosci (2015) 0.92
Modulation of iron metabolism in aging and in Alzheimer's disease: relevance of the choroid plexus. Front Cell Neurosci (2012) 0.90
Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels. J Biol Chem (2010) 0.90
Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer's disease: an observational study. BMC Neurol (2014) 0.89
Plasma alkaline phosphatase is elevated in Alzheimer's disease and inversely correlates with cognitive function. Int J Mol Epidemiol Genet (2011) 0.85
Insulin-like growth factor I and the pathogenesis of delirium: a review of current evidence. J Aging Res (2011) 0.82
Growth hormone treatment in young children with Down's syndrome: effects on growth and psychomotor development. Arch Dis Child (1999) 0.81
Amyloid-β transmission or unexamined bias? Nature (2016) 0.79
Amyloid beta-mediated epigenetic alteration of insulin-like growth factor binding protein 3 controls cell survival in Alzheimer's disease. PLoS One (2014) 0.78
Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders. Mol Autism (2014) 0.78
Collinge et al. reply. Nature (2016) 0.75
Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease. PLoS One (2016) 0.75
Insulin-like growth factor binding protein-2 interactions with Alzheimer's disease biomarkers. Brain Imaging Behav (2016) 0.75
Up-regulation of insulin-like growth factor 2 by ketamine requires glycogen synthase kinase-3 inhibition. Prog Neuropsychopharmacol Biol Psychiatry (2016) 0.75
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology (2007) 2.63
Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci (1997) 2.59
The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol (2000) 2.37
Neuronal nicotinic receptors in the human brain. Prog Neurobiol (2000) 2.31
Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls. Neurology (2009) 2.27
Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ (1996) 2.20
Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology (1997) 2.14
Validity of self-reported stroke : The Tromso Study. Stroke (2000) 2.09
Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology (1991) 2.05
Purification of somatomedin-C from human plasma: chemical and biological properties, partial sequence analysis, and relationship to other somatomedins. Biochemistry (1980) 1.86
Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease. Neurology (2006) 1.85
Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology (1999) 1.78
Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol (1994) 1.64
Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport (2001) 1.63
Premedication with midazolam delays recovery after ambulatory sevoflurane anesthesia in children. Anesth Analg (1999) 1.62
Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease. Biol Psychiatry (1996) 1.56
Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord (1998) 1.55
Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology (1992) 1.54
Institutionalization in the elderly: the role of chronic diseases and dementia. Cross-sectional and longitudinal data from a population-based study. J Clin Epidemiol (2001) 1.54
Ammonia, a selective agent for methane production by syntrophic acetate oxidation at mesophilic temperature. Water Sci Technol (2008) 1.52
Dementia is the major cause of functional dependence in the elderly: 3-year follow-up data from a population-based study. Am J Public Health (1998) 1.51
Growth retardation in Down syndrome in relation to insulin-like growth factors and growth hormone. Am J Med Genet Suppl (1990) 1.51
Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol (1999) 1.50
Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging (2000) 1.49
Altered blood-brain-barrier function in Alzheimer's disease? Acta Neurol Scand (1994) 1.44
Treatment of Alzheimer disease with tacrine: a cost-analysis model. Alzheimer Dis Assoc Disord (1997) 1.42
Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport (1999) 1.38
Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. J Clin Epidemiol (1999) 1.38
[More accurate diagnosis could identify patients suitable for tacrine therapy]. Lakartidningen (1996) 1.37
PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease. Brain (2008) 1.34
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months. Neurology (2002) 1.30
Risk factors for late-onset Alzheimer's disease: a population-based, case-control study. Ann Neurol (1993) 1.29
Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study. Neurology (2011) 1.26
Accuracy of the Mini-Mental Status Examination as a screening test for dementia in a Swedish elderly population. Acta Neurol Scand (1993) 1.25
No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes. Arch Neurol (1997) 1.25
Smoking and the occurrence of Alzheimer's disease: cross-sectional and longitudinal data in a population-based study. Am J Epidemiol (1999) 1.24
High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters. Curr Alzheimer Res (2010) 1.23
Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem (2000) 1.23
Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch Neurol (1999) 1.23
Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia. J Chem Neuroanat (2001) 1.20
Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol (1998) 1.18
Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm. J Am Geriatr Soc (1998) 1.17
Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behav Brain Res (1993) 1.17
Ontogenesis of somatomedin and insulin receptors in the human fetus. J Clin Invest (1983) 1.17
Expression of IGF-I and -II mRNA in the brain and craniofacial region of the rat fetus. Development (1991) 1.14
Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Project. Am J Epidemiol (1997) 1.13
Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study. Dement Geriatr Cogn Disord (2006) 1.11
Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch Neurol (1996) 1.11
Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J Neural Transm Park Dis Dement Sect (1992) 1.11
Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels. Neurobiol Aging (2006) 1.11
Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease. Clin Neurophysiol (2000) 1.11
Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dement Geriatr Cogn Disord (2000) 1.10
Brain activation in young and older adults during implicit and explicit retrieval. J Cogn Neurosci (1997) 1.09
Aspirin, NSAIDs, risk of dementia, and influence of the apolipoprotein E epsilon 4 allele in an elderly population. Neuroepidemiology (2004) 1.09
Harmonized diagnostic criteria for Alzheimer's disease: recommendations. J Intern Med (2014) 1.07
The expression of insulin-like growth factor I and insulin-like growth factor II genes in the human fetal and adult brain and in glioma. Neurosci Lett (1988) 1.07
Postnatal changes of nicotinic acetylcholine receptor alpha 2, alpha 3, alpha 4, alpha 7 and beta 2 subunits genes expression in rat brain. Int J Dev Neurosci (1998) 1.07
Variant Alzheimer's disease with spastic paraparesis: clinical characterization. Neurology (2000) 1.06
Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease. Neurosci Lett (1994) 1.06
Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain. Brain Res Mol Brain Res (1999) 1.06
Safety of lumbar puncture procedures in patients with Alzheimer's disease. Curr Alzheimer Res (2009) 1.05
Mortality in nondemented subjects with cognitive impairment: the influence of health-related factors. Am J Epidemiol (1999) 1.05
Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study. Dement Geriatr Cogn Disord (2010) 1.04
Growth and somatomedins. Vitam Horm (1983) 1.04
Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study. Eur J Neurol (2009) 1.03
Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci Lett (1986) 1.03
Regulation of alpha- and beta-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the alpha-secretase pathway. Biochem Biophys Res Commun (2007) 1.03
Regional distribution of nicotinic receptors during prenatal development of human brain and spinal cord. Brain Res Dev Brain Res (1998) 1.02
Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients. J Neurochem (2004) 1.02
Characterization of somatomedins from human fetal brain: identification of a variant form of insulin-like growth factor I. Proc Natl Acad Sci U S A (1986) 1.02
Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress. Neurobiol Dis (2007) 1.01
Muscarinic receptors in human SH-SY5Y neuroblastoma cell line: regulation by phorbol ester and retinoic acid-induced differentiation. Brain Res (1987) 1.01
Can a physician recognize an older driver with increased crash risk potential? J Am Geriatr Soc (1996) 1.01
Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women. Neurosci Lett (2000) 1.00
Mild cognitive impairment in the population and physical health: data on 1,435 individuals aged 75 to 95. J Gerontol A Biol Sci Med Sci (2000) 0.99
Low blood pressure and incidence of dementia in a very old sample: dependent on initial cognition. J Am Geriatr Soc (1999) 0.99
Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment. J Neural Transm (Vienna) (2006) 0.99
Development of ligands for in vivo imaging of cerebral nicotinic receptors. Behav Brain Res (2000) 0.98
Bacterial aerosols in dental practice - a potential hospital infection problem? J Hosp Infect (2006) 0.98
Mini-Mental State Examination item scores as predictors of Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. J Gerontol A Biol Sci Med Sci (1997) 0.98
Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations. Exp Neurol (2001) 0.97
Reduced levels of Abeta 40 and Abeta 42 in brains of smoking controls and Alzheimer's patients. Neurobiol Dis (2004) 0.96
Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication? Am J Epidemiol (2001) 0.96
Comparison of Abeta levels in the brain of familial and sporadic Alzheimer's disease. Neurochem Int (2009) 0.96
Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen Project. Neurology (2000) 0.96
Increase of insulin-like growth factor (IGF)-1, IGF binding protein-2 and -4 mRNAs following cerebral contusion. Brain Res Mol Brain Res (1996) 0.96
Isolation and characterization of variant IGF-1 as well as IGF-2 from adult human brain. FEBS Lett (1986) 0.96
Memory complaints of elderly people in a population survey: variation according to dementia stage and depression. J Am Geriatr Soc (1993) 0.95
Clinical staging of dementia in a population survey: comparison of DSM-III-R and the Washington University Clinical Dementia Rating Scale. Acta Psychiatr Scand (1992) 0.94
The pathogenesis of CADASIL: an update. J Neurol Sci (2004) 0.94
Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients. Dement Geriatr Cogn Disord (2001) 0.94
Regulation of nicotinic receptors in the brain of mice withdrawn from chronic oral nicotine treatment. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.94
Regional deposition of inhaled 11C-nicotine vapor in the human airway as visualized by positron emission tomography. Clin Pharmacol Ther (1995) 0.94
Insulin-like growth factor 1 (IGF-1) receptors in the human brain: quantitative autoradiographic localization. Brain Res (1989) 0.93